EUVIMEDEUVIMED entdecken
Kohortenstudie

Association of extracorporeal therapy with persistent neurologic sequelae after lithium poisoning: A multicentre cohort study

Amir Shabaka iD, Eugenia Landaluce-Triska, Maria José Ortega Fernández-Reyes, Miguel Martínez-Belotto, Mario Botella, Ana Mendoza-Cedeño, Verónica Rubio Menéndez, Javier Vian, Clara Cases-Corona, Fabio Procaccini, Maria Jose Alcaide-Martin, Maria Patricia Sanz-de Pedro und 5 weitere

British Journal of Clinical Pharmacology · 08.10.2026

DOI: 10.1002/bcp.70864 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift British Journal of Clinical Pharmacology, online erschienen am 08.10.2026. Verfasst von Amir Shabaka und 16 weiteren Autor:innen. Beteiligte Einrichtung: Nephrology Department, Hospital Universitario La Paz, Madrid, Spain. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 18 Literaturangaben. Gefördert von: Instituto de Salud Carlos III (ISCIII), European Union, European Commission.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Lithium poisoning may result in persistent neurologic sequelae, including irreversible neurotoxicity. Although extracorporeal therapy enhances lithium elimination, its effect on clinically meaningful outcomes remains uncertain. We evaluated the association between extracorporeal therapy and persistent neurologic sequelae in patients with lithium poisoning.

Methods

We conducted a multicentre retrospective cohort study including 268 patients with lithium poisoning from four tertiary hospitals in Spain. The primary outcome was persistent neurologic sequelae for ≥2 months. Secondary outcomes included mortality, hospital length of stay and treatment‐related complications. Multivariable logistic regression and propensity score weighting were used to adjust for differences in baseline severity and treatment indication.

Results

Among 268 patients, 108 (40.3%) received extracorporeal therapy. Patients receiving extracorporeal therapy had more severe poisoning, with higher peak lithium concentrations and more frequent acute kidney injury and neurologic manifestations. Persistent neurologic sequelae occurred in 55 patients (20.5%) and were less frequent among patients treated with extracorporeal therapy (11.1% vs . 26.9%; p = 0.002). In multivariable analysis, extracorporeal therapy was independently associated with lower odds of persistent neurologic sequelae (adjusted odds ratio 0.20, 95% CI 0.09–0.45). Higher peak lithium concentration and pre‐existing neurologic disease were independently associated with persistent neurologic sequelae. Findings remained consistent after propensity score weighting. The association was strongest among patients meeting EXtracorporeal TReatments In Poisoning (EXTRIP)‐recommended criteria.

Conclusions

Extracorporeal therapy was associated with a lower frequency of persistent neurologic sequelae in lithium poisoning, particularly among patients meeting EXTRIP Workgroup ‘recommended’ criteria. Prospective studies are needed to confirm these findings, particularly in intermediate‐risk poisoning.

Schlagwörter

Stichwörter der Autor:innen

dialysislithium intoxicationneurotoxicitytoxicology

Autor:innen und Institutionen

  • Nephrology Department, Hospital Universitario La Paz, Madrid, Spain.
  • Nephrology Department, Hospital Universitario Fundación Alcorcón, Madrid, Spain.
  • Nephrology Department, Hospital Universitario Marqués de Valdecilla, Santander, Spain.
  • Nephrology Department, Hospital Universitario Infanta Leonor, Madrid, Spain.
  • Laboratory Department, Hospital Universitario La Paz, Madrid, Spain.
  • Laboratory Department, Hospital Universitario Fundación Alcorcón, Madrid, Spain.

ORCID-Profile: Amir Shabaka

Förderung

  • Instituto de Salud Carlos III (ISCIII)
  • European Union
  • European Commission

Zitieren

APA

Shabaka, A., Landaluce-Triska, E., Ortega Fernández-Reyes, M. J., Martínez-Belotto, M., Botella, M., Mendoza-Cedeño, A., Rubio Menéndez, V., Vian, J., Cases-Corona, C., Procaccini, F., Alcaide-Martin, M. J., Sanz-de Pedro, M. P., Gómez Rioja, R., Acedo, J. M., Rivas, B., Vega, C., & Fernández-Juárez, G. (2026). Association of extracorporeal therapy with persistent neurologic sequelae after lithium poisoning: A multicentre cohort study. British Journal of Clinical Pharmacology. https://doi.org/10.1002/bcp.70864

Vancouver

Shabaka A, Landaluce-Triska E, Ortega Fernández-Reyes MJ, Martínez-Belotto M, Botella M, Mendoza-Cedeño A, et al. Association of extracorporeal therapy with persistent neurologic sequelae after lithium poisoning: A multicentre cohort study. British Journal of Clinical Pharmacology. 2026. doi:10.1002/bcp.70864

BibTeX
@article{Shabaka2026,
  author = {Shabaka, Amir and Landaluce-Triska, Eugenia and Ortega Fernández-Reyes, Maria José and Martínez-Belotto, Miguel and Botella, Mario and Mendoza-Cedeño, Ana and Rubio Menéndez, Verónica and Vian, Javier and Cases-Corona, Clara and Procaccini, Fabio and Alcaide-Martin, Maria Jose and Sanz-de Pedro, Maria Patricia and Gómez Rioja, Rubén and Acedo, Juan Manuel and Rivas, Begoña and Vega, Cristina and Fernández-Juárez, Gema},
  title = {Association of extracorporeal therapy with persistent neurologic sequelae after lithium poisoning: A multicentre cohort study},
  journal = {British Journal of Clinical Pharmacology},
  year = {2026},
  doi = {10.1002/bcp.70864}
}
Kostenlos starten →